BCMA: BeCoMing a new hope for AL amyloidosis
In this issue of Blood, Vianna et al 1 provide new evidence for the activity of B-cell maturation antigen (BCMA)-targeting bispecifics in light-chain (AL) amyloidosis, highlighting the activity of elranatamab in daratumumabrefractory patients.
Authors
- Efstathios Kastritis (ORCID: https://orcid.org/0000-0001-8191-5832)
Institutions
- National and Kapodistrian University of Athens (GR)
Publication Details
- Journal
- Blood
- Published
- 2025-10-16
- DOI
- https://doi.org/10.1182/blood.2025030526
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00